---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-113901"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:23:24.052999+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Tvardi Therapeutics posts updated corporate presentation on Nov 19, 2025; full details unavailable

## Summary
- Corporate presentation is available on company's website as of November 19, 2025.
- Exhibit 99.1 only contains header 'Overview November 2025' with no specific data provided in filing excerpt.
- No financial or operational updates, guidance changes, or material events are disclosed in the available text.

## SEC filing metadata
- accession: 0001104659-25-113901
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465925113901/0001104659-25-113901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465925113901/tm2531635d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-113901
- JSON: https://secwatch.observer/filing/0001104659-25-113901.json
- Plain text: https://secwatch.observer/filing/0001104659-25-113901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.